Comprehensive genetic health screen (Whole Exome Sequencing) and complete of pharmacogenomics profile
Comprehensive genetic health screen using Whole Exome Sequencing (WES) and complete profile of pharmacogenomics profile is the proactive genetic testing that predicts the risk of hereditary cancer, cardio, and other associated conditions and the complete drug-genes related to hypersensitivity & metabolism covering more than 150 prescribed drugs.
SEE PACKAGE DETAILS
* See package details for currency conversion.